Notes
• Data are sourced from the Australian Institute of Health and Welfare. More information about data sources can be found in the ‘About the Data’ tab.
• Error bars indicate 95% confidence intervals.
• Relative survival for Registry-Derived stage was calculated using the cohort method, using the period 2011–2016.
• Survival greater than 100% applies where the survival of people with cancer exceeds the survival of people in the general population of equivalent age and sex over an equivalent time period.
• Data for some categories that do not appear in the charts have been deliberately suppressed due to small numbers, confidentiality, and/or reliability concerns.
• Survival estimates for cases for which stage at diagnosis was 'unknown' have not been displayed in the chart as this category will be comprised of cases with varying stage at diagnosis. For all persons, the 1, 3, and 5-year relative survival rates were 96.6%, 92.9% and 90.8%, respectively.
• Error bars indicate 95% confidence intervals.
• Relative survival for Registry-Derived stage was calculated using the cohort method, using the period 2011–2016.
• Survival greater than 100% applies where the survival of people with cancer exceeds the survival of people in the general population of equivalent age and sex over an equivalent time period.
• Data for some categories that do not appear in the charts have been deliberately suppressed due to small numbers, confidentiality, and/or reliability concerns.
• Survival estimates for cases for which stage at diagnosis was 'unknown' have not been displayed in the chart as this category will be comprised of cases with varying stage at diagnosis. For all persons, the 1, 3, and 5-year relative survival rates were 96.6%, 92.9% and 90.8%, respectively.